Newsroom

Newsroom

NeoGenomics Appoints Dr. Lawrence M. Weiss as Chief Scientific Officer

Press Release
Read More

NeoGenomics Announces Pricing on Secondary Offering of Common Stock by Selling Stockholder

Press Release
Read More

NeoGenomics Announces Secondary Offering of Common Stock by Selling Stockholder

Press Release
Read More

NeoGenomics Completes Acquisition of Genoptix, Inc.

Press Release
Read More

NeoGenomics Reports 17% Revenue Growth to Record $69 Million

Press Release
Read More

Characterization of Myeloid-Derived Suppressor Cells and Tumor Associated Macrophages Using MultiOmyx™ Hyperplexed Immuno-Assay in Hodgkin Lymphoma

Literature
Read More

Using a Multiplexed Immunofluorescence Assay to Detect Immunosuppressive Cells and their Mechanisms in the Pancreatic Tumor Microenvironment

Literature
Read More

Using MultiOmyx™ to Analyze Correlations between Immunosuppressive Cells and Tumor-Infiltrating Lymphocytes in the Pancreatic Tumor Microenvironment

Literature
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients